| abstract |
Disclosed is an inhibitor of influenza virus replication. A method of inhibiting influenza virus replication in a biological sample or patient, reducing the amount of influenza virus in the biological sample or patient, and treating a patient's influenza is as described above. Administering an effective amount of a compound represented by structural formula (I) or a pharmaceutically acceptable salt thereof, wherein the value of structural formula (I) is as defined herein. As described in the book. The compound is represented by Structural Formula (I), or a pharmaceutically acceptable salt thereof, in which case the value of Structural Formula (I) is as described herein. The pharmaceutical composition comprises an effective amount of a compound as described above or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, adjuvant or vehicle. [Selection figure] None |